Manager – R&D Strategic Partnerships
Illumina
Manager – R&D Strategic Partnerships
Illumina
Develops sequencing platforms and consumables
Position Summary
Illumina is seeking a Manager, R&D Strategic Partnerships with strong program management expertise to lead execution across complex, R&D strategic partnerships and strategic account programs. This role will translate strategic objectives and partner commitments into actionable program plans, establish effective governance, guide cross-functional teams, and coordinate delivery across R&D and other functions. Depending on the partnership model, the role may also manage the external partner relationship and lead formal joint governance.
Because the portfolio is evolving, the successful candidate must be comfortable bringing structure to ambiguity, working independently, managing multiple programs, and communicating effectively with internal leaders and external stakeholders.
Key Responsibilities
Qualifications and Success Profile
Education and Experience
All listed responsibilities and requirements are essential functions of the position; business conditions may require reasonable accommodations or additional related duties.
#LI-ONSITE
The estimated base salary range for the Manager, R&D Strategic Partnerships role based in the United States of America is: $129,400 - $194,000. Should the level or location of the role change during the hiring process, the applicable base pay range may be updated accordingly. The range reflects long‑term growth in the role; therefore, most candidates are hired between the minimum and middle of the range. Placement depends on experience, skills, location, and internal equity. Additionally, all employees are eligible for one of our variable cash programs (bonus or commission) and eligible roles may receive equity as part of the compensation package. We offer a wide range of benefits as innovative as our work, including access to genomics sequencing, family planning, health/dental/vision, retirement benefits, and paid time off.Illumina develops and sells integrated sequencing systems and the consumables needed to analyze genetic variation and biological function. Its instruments use sequencing-by-synthesis on flow-cell-based platforms, with specialized reagents and library preparation kits that are consumed per run. The company differentiates itself through a broad end-to-end ecosystem, a large installed base that drives repeat purchases, and strategic acquisitions that expand capabilities into multiomics and clinical applications. Its goal is to advance genomic analysis for research and clinical diagnostics to enable personalized medicine and early cancer detection.
Explore more opportunities at Illumina